ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter ...

Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, discusses positive preclinical data recently presented at the Society for Immunotherapy of Cancer ...

After a drawn-out acquisition that closed in 2023, U.K. biotech F-star Therapeutics is charting its own path as a private, ...

Prudential Financial Inc. increased its holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 177.7% in the ...

KLP Kapitalforvaltning AS bought a new position in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) during the ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

MORRISVILLE, N.C., March 12, 2025--(BUSINESS WIRE)--PharmaCord LLC ("PharmaCord"), a leading provider of patient services for the biopharmaceutical industry, and Mercalis, an integrated life ...

B. subtilis spores are stable across a wide temperature range, which reduces the cost of storage and transportation.

In downstream processing of biopharmaceutical products, protein aggregation presents one of the main risks in terms of therapeutic efficacy, safety and quality of these products. This study ...

Privo Technologies, a phase 3 clinical-stage biopharmaceutical company specializing in drug delivery and cancer treatment in ...

JEFFERSONVILLE, Ind. & MORRISVILLE, N.C.--(BUSINESS WIRE)--PharmaCord LLC (“PharmaCord”), a leading provider of patient services for the biopharmaceutical ...